3858 results for «2254»
3858 results
Stroke Prevention Day - Essentials in LAA closure
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patient selection for LAA closure, the importance of TEE/CT imaging to identify LAA anatomy/morphology, and discover how to detect immediate/late complications and how to manage them, thanks to a selection of various challenging cases.
Abstracts from submissions - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to read 3 of the abstracts submitted for PCR Tokyo Valves 2020: thrombocytopenia after transfemoral TAVI, current generation transcatheter aortic valves in patients with large aortic annuli, and TAVI with Evolut R vs. Sapien 3 in small aortic annulus.
PCR Tokyo Valves 2020: Selection of the 2020 best clinical cases
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best clinical cases presented during PCR Tokyo Valves 2020: unusual cause of coronary artery obstruction after TAVI, simultaneous TAVR-in-TAVR and valve-in-mitral-annular-calcification intervention, paravalvular leak with valve-in-valve TAVR and bioprosthetic ring fracturing, and more!
Stroke Prevention Day - PFO
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn how to build a stroke prevention team, what are the indications and pre-procedural screening of PFO closure, and discover the step-by-step procedure of PFO closure thanks to a selection of cases and studies.
PCR Tokyo Valves 2020: Selection of the best abstracts
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best abstracts submitted at PCR Tokyo Valves 2020: the efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy, inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve, and more!
Remaining limitation of TAVI
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases.
Aortic Valve Thrombosis
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
How to optimise PCI in a patient with multivessel disease? LIVE Case
19 Dec 2019 – From GulfPCR-GIM 2019
Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.
The objectives of this case are:
- Assess your patient as a whole package!
- Lesion preparation is key for...
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
Challenging cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Closing Ceremony and Highlights of the Course: PCR London Valves 2018
11 Sep 2018 – From PCR London Valves 2018
Join B. Prendergast for the closing ceremony of PCR London Valves 2018 and discover the course highlights!
Opening Ceremony: PCR London Valves 2018
10 Sep 2018 – From PCR London Valves 2018
Join J. J. Bax, B. Prendergast and J. Fajadet for the opening ceremony of PCR London Valves 2018 and find out more about the global challenge of the increasing burden of heart disease and the new technologies for the treatment of SHD.
Complications of TAVI
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about how to identify which patients are high risks for complication, how to use imaging in procedural planning, and how to treat TAVI related complications (valve embolization, paravalvular leak, and more!).
Closing Ceremony - PCR Tokyo Valves 2019
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of the PCR Tokyo Valves 2019 closing ceremony, including the best clinical case presenters awards.
Hot topics in the pharmacologic treatment after TAVI – Current concepts
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI and the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI.
Safety and effectiveness of transcatheter mitral leaflet approximation with MitraClip in heart failure patients with secondary mitral regurgitation
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the safety and effectiveness of transcatheter mitral leaflet approximation with MitraClip in heart failure patients with secondary mitral regurgitation, thanks to the results of the COAPT and MitraClip Japan trials.
